Hua, H., et al., Reduction of NADPH oxidase 4 in adipocytes contributes to the anti-obesity effect of dihydroartemisinin
Unraveling adipose tissue dysfunction: molecular Mechanisms, novel Biomarkers, and therapeutic targets for liver fat deposition
Metformin, if not contraindicated, is the preferred first line pharmacological agent for type 2 diabetes 14
Thnh phn ca vin ung Glutathione 600 Dr Lacir Collagen type I (300mg) Cao sm t n (150mg) L-Cystine (150mg) Sa ong cha ti (60mg) Nhau thai cu (120mg) Chit xut c mi Pregnenolone acetate (45mg) Vitamin E (30mg) Vitamin C (20mg) Mt s thnh phn khc nh: tinh cht hoa hng, Astaxanthin, vanillin, Vi bng thnh phn hon ton lnh tnh, S kt hp hon ho ca cc thnh phn qu gip h tr duy tr mt ln da sng khe, h tr tr ha ln da
The most commonly reported adverse effects in the Phase 2 trial included: Nausea the most prevalent side effect, particularly during dose escalation Vomiting Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can be uncomfortable) Eructation (belching) Injection-site reactions (such as redness, bruising, or discomfort at the injection site) These effects are typically mild to moderate in severity and tend to be most pronounced during the first few weeks of treatment or following each dose increase